Ellipta DPI (nemiralisib) - GSK
GSK: R&D Event (GSK) - Nov 5, 2015 - Anticipated data from P2 trial in COPD in 2016; Anticipated initiation of P2b trial in COPD at the end of 2016 or beginning of 2017 
Anticipated new P2b trial • Anticipated P2 data • Immunology
http://www.gsk.com/media/853576/randd-day-transcript-full.pdf
 
Nov 5, 2015
 
.